GORE Flow Reversal System and GORE Embolic Filter Extension Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1397 participants.
Also called NCT01343667
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,397 participants
- Sponsor
- Registry
-
NCT01343667
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01343667. Non-randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-11 (actual). Results posted on 2016-02-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- GORE Flow Reversal System and GORE Embolic Filter Extension Study
- Acronym
- FREEDOM
- Condition
- Carotid Stenosis
- Condition
- Constriction, Pathologic
- Condition
- Carotid Artery Diseases
- Condition
- Cerebrovascular Disorders
- Condition
- Brain Diseases
- Condition
- Central Nervous System Diseases
- Condition
- Nervous System Diseases
- Condition
- Arterial Occlusive Diseases
- Condition
- Vascular Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Pathological Conditions, Anatomical
- Intervention (Device)
- Gore Flow Reversal System
- Intervention (Device)
- Gore Embolic Filter
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct01343667- Content hash
ebc203f19b1fa741ce193a5498dddaef6ec7996faca15dbcadc37e20afabd10f